"I’ve worked in the Roche NZ affiliate for more than eight years and am a Senior Medical Affairs assistant. My role consists of drug safety oversight and clinical trial administration. One of my main responsibilities is to ensure that the collection, reporting and handling of safety information associated with Roche products is performed according to global and local regulatory requirements. Reporting all adverse events (side effects) associated with Roche products within specified timelines is crucial in maintaining the safety profile of our medicines. This ensures that clinicians have the most up-to-date safety information available to them when prescribing medicines for New Zealanders. I also provide support to the local study team by managing the payments to clinical trial sites and preparing legal documents for clinical trials. The timely preparation of legal documents for clinical trials means that our trials can start as soon as possible, giving New Zealand patients access to innovative medicines sooner rather than later." "I’ve worked in the Roche NZ affiliate for more than eight years and am a Senior Medical Affairs assistant. My role consists of drug safety oversight and clinical trial administration. One of my main responsibilities is to ensure that the collection, reporting and handling of safety information associated with Roche products is performed according to global and local regulatory requirements. Reporting all adverse events (side effects) associated with Roche products within specified timelines is crucial in maintaining the safety profile of our medicines. This ensures that clinicians have the most up-to-date safety information available to them when prescribing medicines for New Zealanders. I also provide support to the local study team by managing the payments to clinical trial sites and preparing legal documents for clinical trials. The timely preparation of legal documents for clinical trials means that our trials can start as soon as possible, giving New Zealand patients access to innovative medicines sooner rather than later."

drug safety and clinical administration